
Wall Street’s mood swing
Meta is getting a fresh dose of skepticism: the stock was downgraded from Buy to Hold, with a base-case price target of $631. That still implies upside, but not enough to make the market swoon like it used to.
The problem isn’t growth — it’s the bill
Meta is still growing revenue at a healthy 28% year over year, which is the kind of number that normally gets investors doing cartwheels. But the issue is that profitability is getting squeezed by rising R&D spending, while ad metrics are slowing and the company isn’t giving the kind of concrete demand signals that would make all that capex feel easy to swallow.
Why investors care
This is basically the market saying: “Cool story, now show me the receipts.” When a hyperscaler is spending more but can’t clearly prove the payoff, the stock starts to trade less like a growth rocket and more like a very expensive promise.
Big picture: Meta still has momentum, but the bar has shifted. In this market, growth is nice — profitable, well-explained growth is what actually gets rewarded.
